OUR

Products

PET Radiopharmaceuticals

¹⁸F-FDG Injection (Fluorodeoxyglucose)

A PET radiopharmaceutical used for diagnostic imaging in oncology (detection, staging, and monitoring of cancers), cardiology (myocardial viability assessment), and neurology (evaluation of brain metabolism in epilepsy, dementia, and neurodegenerative disorders). It reflects cellular glucose metabolism, highlighting metabolically active tissues.

Future pipeline products

Iodine-131 Capsule

A ready-to-use oral radiopharmaceutical used primarily for thyroid diagnostics and therapy, including hyperthyroidism treatment and thyroid cancer ablation. Supplied in calibrated capsule form for accurate dosing, with lead shielding for safe transport. Available in patient-specific activity ranges, with shelf life dependent on decay and controlled storage conditions.

Iodine-131 Solution

An oral liquid radiopharmaceutical used for similar thyroid applications, including diagnostic uptake studies and therapeutic treatment. The solution allows flexible dosing adjustments and is supplied in shielded vials. Prepared under strict quality controls and calibrated to reference time for accurate administration.

Gallium Generator (⁶⁸Ge/⁶⁸Ga Generator)

A long-lived generator system used to produce Gallium-68 on-site for PET imaging. It enables elution of ⁶⁸Ga for radiolabeling of diagnostic tracers used in oncology (e.g., neuroendocrine tumors, prostate imaging). Designed for repeated use over its validated lifespan, with elution performed under controlled radiopharmacy conditions.

Lutetium-177 (Lu-177)

A therapeutic radiopharmaceutical isotope used in targeted radionuclide therapy, particularly for neuroendocrine tumors and prostate cancer when labeled with specific ligands. It emits beta radiation for treatment and gamma radiation for imaging/monitoring. Supplied in shielded vials with calibrated activity, supporting precision oncology applications.